The Yale Center for the Science of Cannabis and Cannabinoids recently released their list of inaugural Pilot Award winners.
A recent press release announced the Yale Center for the Science of Cannabis and Cannabinoids (YC-SCAN²) revealed their Pilot Award winners (1). The award program provides over $600,000 worth of grants to 14 researchers from the Yale School of Medicine. With these funds, researchers will be able to use them on a variety of projects that will study the effects cannabis and cannabinoids have on mental health and neurodevelopment. Once the research studies gather and review the data, the information is then made available so that the public, scientific community, and healthcare professionals are able to be educated on the data findings.
In 2023, YC-SCAN² was founded and aimed to provide a space for cannabis research and related studies such as, cannabinoids (1,2). Deepak Cyril D’Souza, MD, Vikram Sodhi ’92 Professor of Psychiatry, directs and manages the program.
“We received a highly competitive set of applications making for a challenging selection process,” D’Souza explained (1). We are grateful to our reviewers who brought their expertise in basic and clinical sciences in reviewing these applications.” He added that (1), “The projects cover a broad range of topics from the effects of cannabinoids on fetal neurodevelopment and adolescent brain development, the therapeutic potential of beta-caryophyllene for pain, to the impact of cannabis in schizophrenia,” he said. “The projects are led by investigators at different stages of their careers utilizing several novel approaches. We are optimistic that these projects will advance the science of cannabis and cannabinoids and bring Yale closer to the forefront of cutting-edge research in the area.”
As mentioned in the press release, funding for the grants was provided by Yale University. Here is a list of the recipients are (1):
References
Ep 24, Part III: Data Transparency in Cannabis Testing with Yasha Kahn
December 26th 2024In the final part of this episode, Evan Friedmann and Yasha Kahn discuss the need for a national entity to centralize cannabis data collection, moving from snapshot data to continuous updates. They emphasize the importance of accurate lab data and adverse event tracking, suggesting QR codes on packaging to report issues. Yasha suggests harsher consequences for result manipulation and suggests collaboration between state departments and federal entities to support underfunded regulators. They also discuss the potential benefits of off-the-shelf testing and the importance of stability testing. Finally, Yasha shares his top three reading recommendations for the audience.
Ep 24, Part II: Data Transparency in Cannabis Testing with Yasha Kahn
December 12th 2024Evan Friedmann and Yasha Kahn, co-founder of MCR Labs, discuss the discrepancies between current regulations and data on mycotoxins and pesticides in cannabis products. They highlight the need for updated regulations based on new data, emphasizing the importance of accurate testing and labeling. They also discuss the issue of result manipulation, particularly in THC content, and the need for public health officials to address this. Yasha suggests making testing data public to enhance oversight and suggests a national entity to manage this data for better consistency and public safety.